지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis
Pediatric Gastroenterology, Hepatology & Nutrition
2024 .07
Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
Gut and Liver
2019 .01
Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
Annals of Surgical Treatment and Research
2023 .04
Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
Gut and Liver
2020 .01
Magnetization-tagged MRI is a simple method for predicting liver fibrosis
Clinical and Molecular Hepatology
2016 .01
Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Gut and Liver
2022 .11
Non-invasive biomarkers, FIB-4 and APRI index, as predictors for prognosis of hepatocellular carcinoma patients after curative hepatectomy
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
만성 B형 및 C형 간염 환자의 간섬유화 진단을 위한 비침습적 혈액 표지자 평가
Laboratory Medicine Online
2019 .01
Evaluation of FIB-4 and APRI in predicting the prognosis of heptocellular carcinoma patients after hepatic resection
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Gut and Liver
2016 .01
Therapeutic effects of Shibashin Misena® against fine-dust-induced pulmonary disorders in mice
한국실험동물학회 학술발표대회 논문집
2020 .02
Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
Gut and Liver
2020 .01
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Clinical and Molecular Hepatology
2021 .01
Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study
Endocrinology and Metabolism
2021 .10
Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes
Endocrinology and Metabolism
2023 .04
Evaluation of Non-invasive Fibrosis Markers in Predicting Esophageal Variceal Bleeding
Clinical Endoscopy
2021 .11
Cellular and Molecular Mechanisms of Intestinal Fibrosis
Gut and Liver
2023 .05
Current role of transient elastography in the management of chronic hepatitis B patients
ULTRASONOGRAPHY
2017 .01
Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
Annals of Laboratory Medicine
2021 .01
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients
Clinical and Molecular Hepatology
2019 .01
0